Ftse Mib
33.629,21
-0,32%
DAX
18.001,60
0,54%
S&P 500
5.127,79
1,26%
NASDAQ
16.156,33
1,99%
Bitcoin
63.993,06
-0,01%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ AVROBIO Inc (AVRO) AVROBIO Inc (AVRO) Notizie

AVROBIO Inc

AVRO
1,22
-0,01 (-0,81%)
04 Mag 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
27/2/202416:50PRNUSKuehn Law Encourages CHRD, AVRO, KAMN, and CTLT Investors to..
23/2/202422:00EDGAR2Form SCHEDULE 13G - Statement of acquisition of beneficial..
06/2/202402:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202401:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202401:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202401:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202420:25PRNUSKuehn Law Encourages ICVX, CSTR, AVRO, and CALB Investors to..
30/1/202422:47EDGAR2Form 425 - Prospectuses and communications, business..
30/1/202422:07EDGAR2Form 425 - Prospectuses and communications, business..
30/1/202422:05EDGAR2Form 8-K - Current report
30/1/202415:05EDGAR2Form 425 - Prospectuses and communications, business..
30/1/202414:39EDGAR2Form 8-K - Current report
30/1/202414:00BWAVROBIO and Tectonic Therapeutic Announce Merger
09/11/202322:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03/11/202321:15EDGAR2Form RW - Registration Withdrawal Request
10/8/202322:32EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
12/7/202313:13EDGAR2Form 8-K - Current report
12/7/202313:00BWAVROBIO to Explore Strategic Alternatives
03/7/202319:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/6/202313:00BWAVROBIO Completes Sale of Cystinosis Gene Therapy Program..
22/5/202313:00BWAVROBIO Announces Agreement to Sell Cystinosis Gene Therapy..
18/5/202314:14DJNAvrobio Stock Up 16% on Positive Data for Cystinosis..
18/5/202313:00BWAVROBIO Announces Positive Data from Phase 1/2 Clinical..
11/5/202313:00BWAVROBIO Reports First Quarter 2023 Financial Results and..
Apertura: 1,23 Min: 1,18 Max: 1,24
Chiusura: 1,23

La tua Cronologia

NASDAQ
AVRO
AVROBIO
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network